NCT06250751

Brief Summary

To refine a remote behavioral exercise training intervention for testing in a larger randomized trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for not_applicable prostate-cancer

Timeline
Completed

Started Feb 2024

Shorter than P25 for not_applicable prostate-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 30, 2024

Completed
6 days until next milestone

Study Start

First participant enrolled

February 5, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 9, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 6, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 6, 2025

Completed
Last Updated

October 31, 2025

Status Verified

October 1, 2025

Enrollment Period

1.7 years

First QC Date

January 30, 2024

Last Update Submit

October 30, 2025

Conditions

Keywords

ExerciseProstate CancerAndrogen Deprivation Therapy (ADT)Home Based Exercise Intervention

Outcome Measures

Primary Outcomes (3)

  • Feasibility of trial by assessing the recruitment rate

    The number of participants that enroll

    Day 1

  • Feasibility of trial by assessing the retention rate

    The number of participants that complete greater than 80% of the planned assessments

    12 Weeks

  • Acceptability of the trial by assessing the retention rate

    Number of participants that adhere to and complete the intervention

    12 Weeks

Secondary Outcomes (18)

  • Physical activity levels using accelerometry (ActivPAL, Actigraph)

    Baseline, 8 Weeks, and 12 Weeks

  • Physical activity levels using the Godin-Leisure Time Exercise Questionnaire (GLTEQ).

    Baseline, 8 Weeks, and 12 Weeks

  • Submaximal exercise capacity assessed with the 6-minute walk test.

    Baseline, 8 Weeks, and 12 Weeks

  • Physical function as assessed with the short physical performance battery (SPPB).

    Baseline, 8 Weeks, and 12 Weeks

  • Lower body strength assessed with a 30 seconds chair stand test.

    Baseline, 8 Weeks, and 12 Weeks

  • +13 more secondary outcomes

Study Arms (1)

Behavioral exercise training (BET) to introduce behavioral skills for adopting an exercise program

EXPERIMENTAL

Single-arm, ORBIT-prospective, multicenter, nonblinded clinical trial, feasibility pilot. The BET intervention will be delivered and refined over 12 weeks. The protocol aim is to enroll men from the same representative groups of underserved men in groups of 5-10, to foster social support and group cohesion.

Behavioral: Behavioral Exercise Training (BET) intervention

Interventions

Introduce and refine concept of exercise and cardiovascular health by initiating walking or cycling and provide behavioral counseling sessions to foster support for adoption and maintenance of exercise, and to troubleshoot barriers. During the first two weeks, the study team will meet with participants twice per week (virtually) to introduce the intervention, familiarize men with the exercise program, exercise logs, resistance bands for strength training. Contact will drop to once per week during weeks 3-8 (total=10 contacts in weeks 1-8). Behavioral counseling will be delivered by the PI or the study coordinator for 30-40 minutes prior to 20-30 mins of an individual or group-based strength training class.

Behavioral exercise training (BET) to introduce behavioral skills for adopting an exercise program

Eligibility Criteria

Age41 Years - 85 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • To be eligible men, transwomen or non-binary individuals must meet the following criteria:
  • Be diagnosed with stage II/III/IV prostate cancer
  • Be currently undergoing treatment with ADT (intermittent or prolonged)
  • Have completed local curative-intent treatment, including prostatectomy or definitive radiation
  • Be \>40 years of age if non-Hispanic Black or rural dwelling; Otherwise \>60 years of age up to 85
  • Be willing to give an informed consent and sign a HIPAA authorization form
  • Not have any hearing or sight impairments that result in the inability to use the telephone or hear normal conversation
  • Must be able to join an intervention group by personal computer, smartphone or telephone call and should agree to recording of an interview
  • Be without any serious medical condition that precludes safe participation in an exercise program
  • Speak English.
  • Meet protocol definition of medically underserved: which is consider medically underserved patients to be a) older men (\>75 years), b) men who live in rural zip code areas, or c) men who identify as being non-Hispanic Black. They may also be at the intersectionality of these groups (i.e., older Black men living in a rural zip code area).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Virginia Commonwealth University

Richmond, Virginia, 23298, United States

Location

MeSH Terms

Conditions

Prostatic NeoplasmsMotor Activity

Interventions

DNER protein, humanMethods

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital DiseasesBehavior

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Alexander Lucas, PhD

    Virginia Commonwealth University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 30, 2024

First Posted

February 9, 2024

Study Start

February 5, 2024

Primary Completion

October 6, 2025

Study Completion

October 6, 2025

Last Updated

October 31, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations